Prognostic impact of EBV-related LMP-1, histologic type, and environmental factors in nasopharyngeal carcinoma in a German population

Onkologie

Volumn 27, Issue 4, 2004, Pages 345-350

  Dietz, A ^a   Logothetis, C A ^b   Helbig, M ^b   Flechtenmacher, C ^c   Rudat, V ^d   Dollner, R ^b   Wallner, F ^b   Bosch, F X ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Epidemiology; LMP 1; Nasopharyngeal carcinoma; Prognostic markers; Risk factors

Indexed keywords

ALCOHOL; PROTEIN; PROTEIN LMP 1; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EMPLOYMENT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; FEMALE; HEALTH HAZARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NASOPHARYNX CARCINOMA; OCCUPATIONAL HEALTH; POPULATION RESEARCH; PROGNOSIS; PROTEIN EXPRESSION; QUESTIONNAIRE; RETROSPECTIVE STUDY; SMOKING; SQUAMOUS CELL CARCINOMA; STANDARDIZATION; TOBACCO; TUMOR VOLUME; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; COCARCINOGENESIS; CROSS-SECTIONAL STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GERMANY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SLOW VIRUS DISEASES; SMOKING;

EID: 4644333855     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079086     Document Type: Article

References (54)

1. Ganzer U: Das Karzinom des Nasopharynx: Anmerkung zu Ätiologie, Diagnostik und Prognose. Strahlenther Onkol 1987;163:519-24.
2. Niedobitek G: Die Epstein-Barr-Virusinfektion in der Pathogenese von Nasopharynx-Karzinomen. Pathologe 1998;19:337-344.
3. IARC: Estimates of cancer incidence and mortality in Europe 1995, Datenbank der International Agency for Research on Cancer: www-dep.iarc.fr.
4. International Histological Classification of Tumours, No. 19: Histological Typing of Upper Respiratory Tract Tumours. Geneva, World Health Organisation, 1978, p32.
5. Shanmugaratnam K, Sobin LH: Histological typing of Tumours of the Upper Respiratory Tract and Ear, ed 2. Geneva, World Health Organization, 1991.
6. Baker SR: Nasopharyngeal carcinoma: Clinical course and results of therapy. Head Neck Surg 1980;3:8.
7. Wolden SL, Zelefsky MJ, Kraus DH, Rosenzweig KE, Chong LM, Shaha AR, Zhang H, Harrison LB, Shah JP, Pfister DG: Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol 2001;19:1105-1110.
8. Costa J: The histopathological diagnosis of nasopharyngeal carcinoma; in Grundmann E, Krueger GRF, Ablashi DV (eds): Nasopharyngeal Carcinoma, Cancer Campaign, vol 5. Stuttgart, Gustav Fischer, 1981, pp 7-10.
9. Old LJ, Boyse EA, Oettgen HF: Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci USA 1966;56:1699-1706.
10. Wolf H, zur Hausen H, Becker V: EB viral genoms in epithelial nasopharyngeal carcinoma cells. Nature 1973;244:245-247.
11. Akao I, SatoY, Mukai K, Sugano S, Hoshikawa T, Suzuki T, Tsutsumi K: Localization of Epstein-Barr virus in lymph node metastasis with nasopharyngeal carcinoma. Acta Otolaryngol Suppl 1996;522:86-88.
12. Chen DL, Huang TB: A case-control study of risk factors of nasopharyngeal carcinoma. Cancer Lett 1997;117:17-22.
13. Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, Chen JY, Liu MY: Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 1990;10(2B):547-553.
14. Cheng YJ, Hildesheim A, Hsu MM, Chen IH, Brinton LA, Levine PH, Chen CJ, Yang CS: Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control 1999;10:201-207.
15. Kieff E: Epstein-Barr virus and its replication; in Fields BN, Knipe DM, Howley PM (eds): Fields Virology, vol 2. Philadelphia, PA, Lipincott-Raven, 1996, pp 2343-2396.
16. Liu MT, Chen YR, Chen SC, Hu CY, Lin CS, Chang YT, Wang WB, Chen JY: Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene 2004;23:2531-2539.
17. Yoshizaki T, Horikawa T, Qing-Chun R, Wakisaka N, Takeshita H, Sheen TS, Lee SY, Sato H, Furukawa M: Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin Cancer Res 2001;7:1946-1951.
18. Yoshizaki T: Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1. Histol Histopathol 2002;17:845-850.
19. Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S: Nasopharyngeal carcinoma in Malaysian Chinese: Salted fish and other dietary exposures. Int J Cancer 1998;77:228-235.
20. Ho JH, Huang DP, Fong YY: Salted fish and nasopharyngeal carcinoma in southern Chinese. Lancet 1978;2:626.
21. Huang DP, Ho JHC, Gough TA: Analyis for volatile nitrosamines in salt-preserved foodstuffs traditionally consumed by southern Chinese; in DeThe G, Ito Y (eds): Nasopharyngeal Carcinoma: Etiology and Control. Lyon, IARC Scientific Publications, 1978, pp 309-314.
22. Huang DP, Ho JHC, Saw D, Teoh TB: Carcinoma of the nasal and paranasal regions in rats fed Cantonese salted marine fish; in DeThe G, Ito Y (eds): Nasopharyngeal Carcinoma: Etiology and Control. Lyon, IARC Scientific Publications, 1978, pp 315-328.
23. Yu MC: Nasopharyngeal Carcinoma: Epidemiological and Dietary Factors. Lyon, IARC Scientific Publications, 1991, pp 39-47.
24. Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC: Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 2000;85:358-363.
25. Zheng X, Yan L, Nilsson B, Eklund G, Drettner B: Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A case-control study in southern China. Acta Oncol 1994;33:867-872.
26. Vaughan TL, Shapiro JA, Burt RD, Swanson GM, Berwick M, Lynch CF, Lyon JL: Nasopharyngeal cancer in a low-risk population: Defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev 1996;5:587-593.
27. Yu MC, Garabrant DH, Huang TB, Henderson BE: Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int J Cancer 1990;45:1033-1039.
28. Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC: Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 2000;85:364-369.
29. Zheng W, McLaughlin JK, Gao YT, Gao RN, Blot WJ: Occupational risks for nasopharyngeal cancer in Shanghai. J Occup Med 1992;34:1004-1007.
30. Zhu K, Levine RS, Brann EA, Gnepp DR, Baum MK: Cigarette smoking and nasopharyngeal cancer: An analysis of the relationship according to age at starting smoking and age at diagnosis. J Epidemiol 1997;7:107-111.
31. Jiong L, Berrino F, Coebergh JW: Variation in survival for adults with nasopharyngeal cancer in Europe, 1978-1989. Eur J Cancer 1998;34:2162-2166.
32. Chang JT, See LC, Liao CT, Chen LH, Leung WM, Chen SW, Chen WC: Early stage nasopharyngeal carcinoma: Radiotherapy dose and time factors in tumour control. Jpn J Clin Oncol 1998;28:207-213.
33. Tombolini V, De Sanctis V, Donateo V, Osti MF, Raffetto N, Santarelli M, Domenico V, De Nicolo M, Enrici RM: Prognostic features and treatment outcome in patients with nasopharyngeal carcinoma: An experience of 20 years. Anticancer Res 2001;21:1413-1418.
34. Itami J, Mikata A, Arimizu N, Ogata H, Miura K, Hayasaki K, Kaneko T: Radiation therapy of the nasopharyngeal cancer and ist prognostic factors. Strahlenther Onkol 1988;164:446-450.
35. Rudat V, Dietz A, Schramm O, Conradt C, Maier H, Flentje M, Wannenmacher M: Prognostic impact of the tumour volume on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol 1999;53:119-125.
36. Teo PML, Leung SF, Yu P, Tsao SY, Foo W, Shiu W: A comparison of Ho's International Union Against Cancer, and American Joint Committee stage classifications for nasopharyngeal carcinoma. Cancer 1991;67:434-439.
37. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS: Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci U S A 1974;71:4737-4741.
38. Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I, Friedrichs R, Lobeck H, Sam CK, Araujo I, Rickinson AB, Stein H: Epstein-Barr virus and carcinomas: Undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991;165:17-24.
39. Niedobitek G, Young LS, Sam CK, Brooks L, Prasad U, Rickinson AB: Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am J Pathol 1992;140:879-884.
40. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Rickinson AB: Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988;69:1051-1065.
41. Raab-Traub N: Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002;12:431-441.
42. Knox PG, Li QX, Rickinson AB, Young LS: In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus: Cell interaction observed in nasopharyngeal carcinoma. Virology 1996;215:40-50.
43. Vera-Sempere F, Burgos J, Botella MS, Morera C: Comparative analysis of Epstein-Barr virus (EBV) detection by nested-PCR and non-isotopic in situ hybridization in nasopharyngeal carcinoma (NPC). Clin Chim Acta 1998;271:119-132.
44. Hu LF, Chen F, Zhen QF, Zhang YW, Luo Y, Zheng X, Winberg G, Ernberg I, Klein G: Differences in the growth pattern and clinical course of EBV-LMP-1 expressing and non-expressing nasopharyngeal carcinomas. Eur J Cancer 1995;31A:658-660.
45. Horikawa T, Yoshizaki T, Sheen TS, Lee SY, Furukawa M: Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 2000;89:715- 723.
46. Gondhowiardjo S: Epstein-Barr Virus latent membrane protein 1 (EBV-LMP-1) and tumour proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response. Jpn J Cancer Chemother 2000;27(Suppl II):323-331.
47. Xu J, Ahmad A, D'Addario M, Knafo L, Jones JF, Prasad U, Dolcetti R, Vaccher E, Menezes J: Analysis and significance of anti-latent membrane protein-1 antibodies in the sera of patients with EBV-associated diseases. J Immunol 2000;164:2815-2822.
48. Tsang NM, Chuang CC, Tseng CK, Hao SP, Kuo TT, Lin CY, Pai PC: Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma. Cancer 2003;98:2385-2392.
49. Hao SP, Tsang NM, Chang KP: Differentiation of recurrent nasopharyngeal carcinoma and skull base osteoradionecrosis by Epstein-Barr virus-derived latent membrane protein-1 gene. Laryngoscope 2001;111:650-652.
50. Abdulkarim B, Sabri S, Zelenika D, Deutsch E, Frascogna V, Klijanienko J, Vainchenker W, Joab I, Bourhis J: Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies. Oncogene 2003;22:2260-2271.
51. Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, Chen JY, Liu MY: Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 1990;10(2B):547-553.
52. Chow WH, McLaughlin JK, Hrubec Z, Nam JM, Blot WJ: Tobacco use and nasopharyngeal carcinoma in a cohort of US veterans. Int J Cancer 1993;55:538-540.
53. Vaughan TL, Shapiro JA, Burt RD, Swanson GM, Berwick M, Lynch CF, Lyon JL: Nasopharyngeal cancer in a low-risk population: Defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev 1996;5:587-593.
54. Schultheiss U, Puschner S, Kremmer E, Mak TW, Engelmann H, Hammerschmidt W, Kieser A: TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. EMBO J 2001;20:5678-5691.